L. Briñas

发表

Monitoring and Characterization of Extended-Spectrum β-Lactamases in Escherichia coli Strains from Healthy and Sick Animals in Spain in 2003

M. C. Porrero, L. Domínguez, C. Torres, 2005, Antimicrobial Agents and Chemotherapy.

Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.

C. Torres, M. Zarazaga, L. Briñas, 2005, The Journal of antimicrobial chemotherapy.

Detection of CTX-M-1 and TEM-52 beta-lactamases in Escherichia coli strains from healthy pets in Portugal.

C. Torres, Y. Sáenz, P. Poeta, 2004, The Journal of antimicrobial chemotherapy.

Outbreak of SHV-5 beta-lactamase-producing Klebsiella pneumoniae in a neonatal-pediatric intensive care unit in Spain.

F. Pérez, C. Torres, M. Zarazaga, 2004, Microbial drug resistance.

Detection of CMY-2, CTX-M-14, and SHV-12 β-Lactamases in Escherichia coli Fecal-Sample Isolates from Healthy Chickens

María García, L. Domínguez, C. Torres, 2003, Antimicrobial Agents and Chemotherapy.

Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.

L. Domínguez, C. Torres, M. Moreno, 2003, Microbial drug resistance.

BEL-1, a Novel Clavulanic Acid-Inhibited Extended-Spectrum β-Lactamase, and the Class 1 Integron In120 in Pseudomonas aeruginosa

P. Nordmann, L. Poirel, L. Briñas, 2005, Antimicrobial Agents and Chemotherapy.

β-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals

C. Torres, F. Ruiz-Larrea, M. Zarazaga, 2002, Antimicrobial Agents and Chemotherapy.

aeruginosa Pseudomonas Class 1 Integron In 120 in-Lactamase , and the β Extended-Spectrum BEL-1 , a Novel Clavulanic Acid-Inhibited

P. Nordmann, L. Poirel, L. Briñas, 2005 .

Mechanisms of Resistance in Multiple-Antibiotic-Resistant Escherichia coli Strains of Human, Animal, and Food Origins

J. Ruiz, J. Vila, C. Torres, 2004, Antimicrobial Agents and Chemotherapy.

Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain.

C. Torres, M. Zarazaga, Y. Sáenz, 2002, Microbial drug resistance.

ColVI myopathies: where do we stand, where do we go?

T. Stojkovic, S. Quijano-roy, P. Richard, 2011, Skeletal Muscle.

Differentiating Emery-Dreifuss muscular dystrophy and collagen VI-related myopathies using a specific CT scanner pattern

B. Eymard, T. Stojkovic, T. Voit, 2010, Neuromuscular Disorders.

Role of dynamin 2 in the disassembly of focal adhesions

S. Vassilopoulos, M. Bitoun, P. Guicheney, 2013, Journal of Molecular Medicine.

Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.

C. Torres, F. Ruiz-Larrea, M. Zarazaga, 2003, The Journal of antimicrobial chemotherapy.